Drug discovery using machine learning

The problem

Early-stage drug discovery is a risky and expensive endeavor, limiting innovation.

The solution

Applying machine learning to drug discovery to lower the cost and open up routes to novel medicines.

Our engagement

Anterra led the Seed investment round supporting the spin-out of ZebiAI from X-Chem.